BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2332269)

  • 1. Serous psammocarcinoma of the ovary and peritoneum.
    Gilks CB; Bell DA; Scully RE
    Int J Gynecol Pathol; 1990; 9(2):110-21. PubMed ID: 2332269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grade 1 peritoneal serous carcinomas: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors.
    Weir MM; Bell DA; Young RH
    Am J Surg Pathol; 1998 Jul; 22(7):849-62. PubMed ID: 9669347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas.
    Bell KA; Smith Sehdev AE; Kurman RJ
    Am J Surg Pathol; 2001 Apr; 25(4):419-32. PubMed ID: 11257616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision making in borderline ovarian tumors: report of a rare case of mesosigma psammocarcinoma.
    Grimaldi L; Danzi M; Reggio S; Pannullo M; Danzi R; Lauria R
    Ann Ital Chir; 2013 Sep; 84(ePub):. PubMed ID: 23995281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
    Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A
    Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique case of ovarian psammocarcinoma with mediastinal, pulmonary, subcutaneous, and omental metastases.
    Chase DM; Sparks DA; Gener M; Smith J
    Arch Gynecol Obstet; 2009 Aug; 280(2):283-6. PubMed ID: 19096859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
    Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
    J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases.
    Raju U; Fine G; Greenawald KA; Ohorodnik JM
    Hum Pathol; 1989 May; 20(5):426-36. PubMed ID: 2707793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion.
    Prat J; De Nictolis M
    Am J Surg Pathol; 2002 Sep; 26(9):1111-28. PubMed ID: 12218568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal serous micropapillomatosis of low malignant potential (serous borderline tumors of the peritoneum). A clinicopathologic study of 17 cases.
    Biscotti CV; Hart WR
    Am J Surg Pathol; 1992 May; 16(5):467-75. PubMed ID: 1599025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
    Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
    Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas.
    Clement PB; Young RH; Scully RE
    Am J Surg Pathol; 1996 Sep; 20(9):1067-80. PubMed ID: 8764743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns.
    Eichhorn JH; Bell DA; Young RH; Scully RE
    Am J Surg Pathol; 1999 Apr; 23(4):397-409. PubMed ID: 10199469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic findings in eight cases of ovarian serous borderline tumors, three with foci of serous carcinoma, that preceded death or morbidity from invasive carcinoma.
    Lee KR; Castrillon DH; Nucci MR
    Int J Gynecol Pathol; 2001 Oct; 20(4):329-34. PubMed ID: 11603215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma.
    Rollins SE; Young RH; Bell DA
    Am J Surg Pathol; 2006 Apr; 30(4):457-62. PubMed ID: 16625091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Extraovarian Implants in Patients With Ovarian Serous Borderline Tumors (Tumors of Low Malignant Potential) Based on Clinical Outcome.
    McKenney JK; Gilks CB; Kalloger S; Longacre TA
    Am J Surg Pathol; 2016 Sep; 40(9):1155-64. PubMed ID: 27428735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian serous tumors of low malignant potential (serous borderline tumors). The relationship of exophytic surface tumor to peritoneal "implants".
    Segal GH; Hart WR
    Am J Surg Pathol; 1992 Jun; 16(6):577-83. PubMed ID: 1599036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic findings of psammocarcinoma in peritoneal washings.
    Pantanowitz L; Otis CN; Goulart RA
    Acta Cytol; 2009; 53(3):263-7. PubMed ID: 19534264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary peritoneal psammocarcinoma: a case presenting synchronously with bowel carcinoma.
    Koumoundourou D; Michail G; Kourounis G; Ravazoula P
    Gynecol Oncol; 2006 Sep; 102(3):576-9. PubMed ID: 16624390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.